AVVAA World Health Care Products, Inc. Logo

AVVAA World Health Care Products, Inc.

AVVH

(1.8)
Stock Price

0,00 USD

-703.33% ROA

56.06% ROE

-0x PER

Market Cap.

1.739.597,00 USD

-12.19% DER

0% Yield

-4677.64% NPM

AVVAA World Health Care Products, Inc. Stock Analysis

AVVAA World Health Care Products, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

AVVAA World Health Care Products, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (56.06%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-0x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-12%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROA

The stock's ROA (-703.33%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

AVVAA World Health Care Products, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

AVVAA World Health Care Products, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

AVVAA World Health Care Products, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

AVVAA World Health Care Products, Inc. Revenue
Year Revenue Growth
2000 0
2001 1 100%
2002 0 0%
2003 0 0%
2004 9.409 100%
2005 13.021 27.74%
2006 18.657 30.21%
2007 95.577 80.48%
2008 13.428 -611.77%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

AVVAA World Health Care Products, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2000 7.275
2001 112.126 93.51%
2002 0 0%
2003 25.997 100%
2004 155.690 83.3%
2005 269.432 42.22%
2006 137.759 -95.58%
2007 157.151 12.34%
2008 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

AVVAA World Health Care Products, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 107.915
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2023 76.880 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

AVVAA World Health Care Products, Inc. EBITDA
Year EBITDA Growth
2000 -266.700
2001 -209.247 -27.46%
2002 -200.553 -4.34%
2003 -808.977 75.21%
2004 -2.060.974 60.75%
2005 -1.192.924 -72.77%
2006 -1.271.633 6.19%
2007 -2.009.910 36.73%
2008 66.386.764 103.03%
2023 -76.880 86451.15%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

AVVAA World Health Care Products, Inc. Gross Profit
Year Gross Profit Growth
2000 0
2001 -3.320 100%
2002 0 0%
2003 0 0%
2004 3.205 100%
2005 6.744 52.48%
2006 -16.062 141.99%
2007 -348.519 95.39%
2008 11.652 3091.07%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

AVVAA World Health Care Products, Inc. Net Profit
Year Net Profit Growth
2000 -267.532
2001 -252.215 -6.07%
2002 37.589 770.98%
2003 -819.608 104.59%
2004 -2.230.958 63.26%
2005 -3.145.775 29.08%
2006 -4.035.067 22.04%
2007 -4.470.747 9.75%
2008 -69.712.900 93.59%
2023 -86.644 -80359%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

AVVAA World Health Care Products, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 -2
2001 -2 0%
2002 1 300%
2003 -7 116.67%
2004 -11 45.45%
2005 -11 0%
2006 -10 -22.22%
2007 -3 -200%
2008 -11 72.73%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

AVVAA World Health Care Products, Inc. Free Cashflow
Year Free Cashflow Growth
2000 -216.624
2001 -159.225 -36.05%
2002 -92.875 -71.44%
2003 -430.028 78.4%
2004 -918.838 53.2%
2005 -1.214.213 24.33%
2006 -1.324.151 8.3%
2007 -1.345.038 1.55%
2008 -57.282 -2248.1%
2023 -19.120 -199.59%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

AVVAA World Health Care Products, Inc. Operating Cashflow
Year Operating Cashflow Growth
2000 -136.923
2001 -159.225 14.01%
2002 -92.875 -71.44%
2003 -415.892 77.67%
2004 -918.838 54.74%
2005 -1.194.594 23.08%
2006 -1.309.104 8.75%
2007 -1.342.252 2.47%
2008 -57.282 -2243.24%
2023 -19.120 -199.59%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

AVVAA World Health Care Products, Inc. Capital Expenditure
Year Capital Expenditure Growth
2000 79.701
2001 0 0%
2002 0 0%
2003 14.136 100%
2004 0 0%
2005 19.619 100%
2006 15.047 -30.38%
2007 2.786 -440.09%
2008 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

AVVAA World Health Care Products, Inc. Equity
Year Equity Growth
2000 66.035
2001 -265.180 124.9%
2002 -96.591 -174.54%
2003 -1.246.240 92.25%
2004 -1.401.348 11.07%
2005 -1.649.227 15.03%
2006 -2.034.535 18.94%
2007 -13.914.814 85.38%
2008 -31.119.182 55.29%
2023 98.809 31594.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

AVVAA World Health Care Products, Inc. Assets
Year Assets Growth
2000 108.912
2001 4.940 -2104.7%
2002 21.045 76.53%
2003 247.248 91.49%
2004 282.411 12.45%
2005 592.663 52.35%
2006 1.712.399 65.39%
2007 637.196 -168.74%
2008 684.895 6.96%
2023 164.250 -316.98%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

AVVAA World Health Care Products, Inc. Liabilities
Year Liabilities Growth
2000 42.877
2001 270.120 84.13%
2002 117.636 -129.62%
2003 1.493.488 92.12%
2004 1.683.759 11.3%
2005 2.241.890 24.9%
2006 3.746.934 40.17%
2007 14.552.010 74.25%
2008 31.804.077 54.24%
2023 65.441 -48499.62%

AVVAA World Health Care Products, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.07
Net Income per Share
-3.27
Price to Earning Ratio
-0x
Price To Sales Ratio
18.2x
POCF Ratio
-0
PFCF Ratio
-1.29
Price to Book Ratio
-0
EV to Sales
35.86
EV Over EBITDA
-1.71
EV to Operating CashFlow
-2.55
EV to FreeCashFlow
-2.55
Earnings Yield
-1817.65
FreeCashFlow Yield
-0.77
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
27.38
Graham NetNet
-10.63

Income Statement Metrics

Net Income per Share
-3.27
Income Quality
0.3
ROE
0.56
Return On Assets
-7.02
Return On Capital Employed
-0.23
Net Income per EBT
-1.4
EBT Per Ebit
1.01
Ebit per Revenue
33.11
Effective Tax Rate
0.41

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
1.64
Stock Based Compensation to Revenue
0
Gross Profit Margin
-3.65
Operating Profit Margin
33.11
Pretax Profit Margin
33.29
Net Profit Margin
-46.78

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.98
Free CashFlow per Share
-0.98
Capex to Operating CashFlow
-0
Capex to Revenue
0.03
Capex to Depreciation
0
Return on Invested Capital
-0.15
Return on Tangible Assets
-7.03
Days Sales Outstanding
106.03
Days Payables Outstanding
613.23
Days of Inventory on Hand
0
Receivables Turnover
3.44
Payables Turnover
0.6
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
-10,18
Tangible Book Value per Share
-10.18
Shareholders Equity per Share
-10.18
Interest Debt per Share
2.21
Debt to Equity
-0.12
Debt to Assets
2.66
Net Debt to EBITDA
-0.84
Current Ratio
0
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-14182719
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
176193.5
Debt to Market Cap
0.97

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

AVVAA World Health Care Products, Inc. Dividends
Year Dividends Growth

AVVAA World Health Care Products, Inc. Profile

About AVVAA World Health Care Products, Inc.

AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.

CEO
Mr. Jason Price
Employee
5
Address
7400 Beaufont Springs Drive
Richmond, 23225

AVVAA World Health Care Products, Inc. Executives & BODs

AVVAA World Health Care Products, Inc. Executives & BODs
# Name Age
1 Mr. Jason Price
Chief Executive Officer, Chief Operating Officer & Director
70
2 Dr. Stephanie Willet
Interim President, Treasurer, Secretary & Director
70

AVVAA World Health Care Products, Inc. Competitors